KalVista Pharmaceuticals, Inc. (KALV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for KalVista Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.73x | -5.00x | -3.30x | -2.66x | -3.78x | -10.31x |
| P/B Ratio | 7.17x | -303.23x | 2.02x | 1.54x | 1.68x | 1.85x |
| P/S Ratio | 0.00x | 11.17x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 91.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -233.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | -223.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -231.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.35x | 5.58x | 9.90x | 11.46x | 16.73x | 27.04x |
| Quick Ratio | 5.35x | 5.52x | 9.90x | 11.46x | 16.73x | 27.04x |
| Leverage | ||||||
| Debt/Equity | 0.07x | -55.91x | 0.04x | 0.05x | 0.04x | 0.02x |
YoY = year-over-year change. Source: FMP..